Abstracts Archive - Page 365 of 1683 - ATC Abstracts

2020 American Transplant Congress
Brincidofovir for Adenovirus Disease in Adult Renal Transplant Recipients: A Case Series
F. Zervou¹, I. Zacharioudakis¹, S. A. Mehta², H. J. Neumann²
¹Infectious Diseases, New York University Langone, New York, NY, ²New York University Langone Transplant Institute, New York, NY
*Purpose: Adenovirus infection can lead to disease in solid organ transplant recipients, including disease of the allograft. Treatment options for severe disease are limited. Brincidofovir…
2020 American Transplant Congress
Opioid Prescription Pattern and Risk Factors Associated with Opioid Use after Living Donor Hepatectomy in the US
M. Nguyen¹, L. Vest², Z. Zhang², V. Whittaker³, M. Schnitzler¹, D. Axelrod⁴, H. Randall¹, C. Varma¹, J. Snyder⁵, B. Kasiske⁵, D. Segev⁶, M. McAdams Demarco⁷, G. Hess⁸, K. Lentine²
¹Department of Surgery, Saint Louis University, Saint Louis, MO, ²Department of Medicine, Saint Louis University, Saint Louis, MO, ³Department of Surgery, New York Medical College, New York, NY, ⁴Department of Surgery, University of Iowa, Iowa City, IA, ⁵SRTR, Minneapolis, MN, ⁶Department of Surgery, Johns Hopkins University, Baltimore, MD, ⁷Johns Hopkins University, Baltimore, MD, ⁸Drexel University, Philadelphia, PA
*Purpose: Opioids are the cornerstone of acute pain management after living donor hepatectomy. Their misuse poses the danger of chronic abuse. How this affects living…
2020 American Transplant Congress
MY-ATLAS: A Novel Simulation Algorithm for Liver Transplant Allocation
C. G. Rickert¹, H. Zhao², Z. Leung², M. Akan³, J. F. Markmann¹, S. Tayur³, H. Yeh¹
¹Surgery, Massachusetts General Hospital, Boston, MA, ²City University of Hong Kong, Hong Kong, China, ³Tepper School of Business, Carnegie Mellon University, Pittsburgh, PA
*Purpose: Currently, the primary tool for modeling expected outcomes from changes in allocation policy is the SRTR-run Liver Simulated Allocation Model (LSAM), which is neither…
2020 American Transplant Congress
Evaluation of Optimization of Workflow for Timing of Inpatient Therapeutic Drug Monitoring of Maintenance Immunosuppressive Drugs in Abdominal Transplant Recipients
J. Schulte, S. Mehta, E. Vargas, K. Cunningham
Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Therapeutic drug monitoring (TDM) is essential to the safety and efficacy of immunosuppressants (IS) given their narrow therapeutic index. After an internal review, it…
2020 American Transplant Congress
Clinical Features and Transplant Outcomes in Kidney Transplant Recipients with Renal Cell Carcinoma
C. Baek, H. Kim, S. Park
Asan Medical Center, Seoul, Korea, Republic of
*Purpose: Previous studies have recommended a 2-5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell…
2020 American Transplant Congress
Analysis of the Quality of Lung Transplantation in Mainland China During 2015- 2018
H. Chun Xiao, L. Xiao Shan, C. Jing Yu
Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China
*Purpose: Lung Transplantation(LT)has been demonstrated as the only effective therapy for patients with end-stage lung diseases. This study aimed to summarize and analyze the data…
2020 American Transplant Congress
Organ and Tissue Donation Education for Transplant Patients Staying at a Transplant Hospitality House Leads to Successful Cornea Donation
T. Giordano¹, L. Suplee², J. L. Weinstock³, R. D. Hasz⁴, H. M. Nathan⁵
¹Family Support Manager, Caregiver Lifeline Program, Gift of Life Family House, Philadelphia, PA, ²Director, Transplant Information Center, Gift of Life Donor Program, Philadelphia, PA, ³Vice President and General Counsel, Gift of Life Donor Program, Philadelphia, PA, ⁴Vice President of Clinical Services, Gift of Life Donor Program, Philadelphia, PA, ⁵President and CEO, Gift of Life Donor Program, Philadelphia, PA
*Purpose: A transplant hospitality house (THH) serving multiple transplant centers is directly connected to its region’s Organ Procurement Organization (OPO) and offers formal education to…
2020 American Transplant Congress
The Accuracy of the ICD-10 Diagnostic Codes for Kidney Transplant Rejection and Failure
D. Massicotte-Azarniouch¹, M. Sood², D. Fergusson³, M. Chassé⁴, A. Tinmouth⁵, G. Knoll²
¹Medicine, University of Ottawa, Ottawa Hospital, Ottawa, ON, Canada, ²Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ³Clinical Epidemiology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁴Medicine, University of Montreal, Ottawa, ON, Canada, ⁵Hematology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada
*Purpose: Clinical research requires that diagnostic codes captured from routinely collected health administrative data accurately identify individuals with a disease. In this study, we examined…
2020 American Transplant Congress
Post-Transplant Blood Borne Infectious Disease Testing in Recipients of Increased Risk Donor Livers: A Single Center Experience
J. Hendele
University of Washington, Seatttle, WA
*Purpose: Increasing the recovery and utilization of donor livers has become a key goal for transplant programs in the United States over the past decade.…
2020 American Transplant Congress
Contrary to Expectation, the Use of Immune Checkpoint Inhibitors is Not Consistently Associated with Early Onset Allograft Rejection in Solid Organ Transplant Recipients
I. Owoyemi¹, C. M. Costello², C. Thongprayoon¹, S. Markovic³, H. Joerg⁴, C. C. Otley⁵, T. Taner⁶, A. R. Mangold², N. Leung¹, S. Herrmann¹, A. Kukla¹
¹Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ²Department of Dermatology, Mayo Clinic, Scottsdale, AZ, ³Division of Medical Oncology, Mayo Clinic, Rochester, MN, ⁴Department of Cardiology, Mayo Clinic, Rochester, MN, ⁵Department of Dermatology, Mayo Clinic, Rochester, MN, ⁶Departments of Surgery & Immunology, Mayo Clinic, Rochester, MN
*Purpose: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are generally avoided in solid organ transplant recipients (SOTRs) due to concern for allograft rejection…